Hired and Retired: Investing in experience
Biotechs continue to pull experienced individuals from larger pharma companies to help progress candidates through the clinic.
A number of biotechs have leaned towards experience when bringing in new recruits this month, with notable figures from Pfizer and GSK joining fledgling companies.
This experience could be particularly useful for two companies working on CRISPR and RNAi technology, as they look to bring these nascent approaches into patients.